Inovio Pharmaceuticals' INO-4800 is one of only 3 to have initiated clinical trials. Investors have responded favorably, sending the stock up by a massive 200% since the turn of the year. INOVIO to Present at RBC Capital Markets Virtual Global Healthcare Conference PR Newswire PLYMOUTH MEETING, Pa., May 12, 2020 PLYMOUTH MEETING, Pa. , May 12, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO) today announced that Dr. J. Joseph Kim , President and CEO, along with other members of management will present in a fireside discussion at the RBC Capital Markets Global Healthcare Conference on If you're interested in Inovio Pharmaceuticals, Inc. (), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio.Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. "Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies." (INO)股票公司摘要,信息或数据由新浪财经美股频道提供 查看完整行情页>> | 货币单位:美元(USD) Inovio Pharmaceuticals, Inc. Inovio Pharmaceuticals, Inc. (ino) Inovio Pharmaceuticals (NASDAQ:INO) A biomedical company which deals in developing human applications of electroporation, which uses brief, controlled electrical pulses to increase cellular uptake of a useful biopharmaceuticals.
Inovio Pharmaceuticals(INO.OQ)股票的最新行情、资讯和评论
Find the latest Inovio Pharmaceuticals, Inc. (INO) stock quote, history, news and other vital information to help you with your stock trading and investing. Stock analysis for Inovio Pharmaceuticals Inc (GBMB:Frankfurt) including stock price, stock chart, company news, key statistics, fundamentals and company profile. INOVIO Pharmaceuticals, Plymouth Meeting, Pennsylvania. 2.8K likes. INOVIO Pharmaceuticals Official Facebook Page - Powering DNA Medicines Overlooked Covid-19 Vaccine Runners Up Defended by Wall Street (Bloomberg) -- Don't give up hope for Novavax Inc. and Inovio Pharmaceuticals Inc., Wall Street analysts said after the two failed to appear on a Trump administration list of Covid-19 vaccine developers picked for Operation Warp Speed.The pair slid more than 10% on Wednesday following a New York Times report saying that the White INO stock has eased off the highs, but a major breakthrough could be just around the corner By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Jun 5, 2020, 3:21 pm EDT If there's one thing that traders have learned about Inovio Pharmaceuticals (NASDAQ:INO) stock, it's that half a year can make a huge difference. Find the latest Inovio Pharmaceuticals, Inc. (INO) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
美股异动 | Inovio Pharmaceuticals(INO.US)涨超12%，股价连续第二日上涨. 智通财经APP获悉，3月4日美股盘初，Inovio Pharmaceuticals(INO.US)股价连续第二日上涨，且成交量超过6700万，该股昨日收涨近70%。 截至北京时间23：28，该股涨12.21%，报8.35美元。
Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania. 公司管治 截至 2019年12月6日 止，Inovio Pharmaceuticals, Inc. 的 ISS 管治質素評分為 3。 股票名稱／代號：Inovio Pharmaceuticals, Inc. (INO) 資料日期：2020/06/06 04:00 AM 台北時間 美股异动 | Inovio Pharmaceuticals(INO.US)涨超12%，股价连续第二日上涨. 智通财经APP获悉，3月4日美股盘初，Inovio Pharmaceuticals(INO.US)股价连续第二日上涨，且成交量超过6700万，该股昨日收涨近70%。 截至北京时间23：28，该股涨12.21%，报8.35美元。 Inovio Pharmaceuticals, Inc.(INO) 本頁資訊為延遲報價20分鐘以上，僅供參考，使用者依本資料交易需自行負責。 最近查閱的股票. 00000000. Inovio Pharmaceuticals（INO）股吧，股票论坛讨论区，让您和专业Inovio Pharmaceuticals Inc股票投资者一起畅所欲言，分析交流Inovio Pharmaceuticals Inc股票的最新动态，行情走势和交易策略。一起讨论Inovio Pharmaceuticals（INO）股票吧。
Inovio Analysts Bullish On Prospects For Coronavirus Vaccine, Biotech's Pipeline Benzinga's Top Upgrades, Downgrades For May 21, 2020 70 Biggest Movers From Yesterday
2019年7月29日- Inovio Pharmaceuticals, Inc.（纳斯达克股票代码：INO）宣布作为其与帕克癌症免疫疗法研究所（PICI）和癌症研究所（CRI）的临床合作协议的一部分， Inovio的前列腺癌免疫疗法INO-5151将与PICI赞助的免疫调节剂（CDX-301，FLT3配体，树突细胞动员剂）和针对转移性去势抵抗性前列腺癌（mCRPC）的PD-1 Get Inovio Pharmaceuticals Inc (INO:NASDAQ) real-time stock quotes, news and financial information from CNBC. 2019年7月29日- Inovio Pharmaceuticals, Inc.（纳斯达克股票代码：INO）宣布作为其与帕克癌症免疫疗法研究所（PICI）和癌症研究所（CRI）的临床合作协议的一部分， Inovio的前列腺癌免疫疗法INO-5151将与PICI赞助的免疫调节剂（CDX-301，FLT3配体，树突细胞动员剂）和针对转移性去势抵抗性前列腺癌（mCRPC）的PD-1
查看最新的 Inovio Pharmaceuticals, Inc. (INO) 股票報價、記錄、新聞及其他重要資訊，助你賣買股票及投資。
取得 Inovio Pharmaceuticals, Inc. (INO) 的最新股票消息和頭條新聞，助你作出交易和投資決策。 在 Yahoo 財經討論區查看最新的 Inovio Pharmaceuticals, Inc. (INO) 股票討論內容。分享你的意見，並參考其他股票交易員和投資者的深入分析。 一種快速簡便的us股票分析方法 技術分析儀表顯示所選時間周期的即時評分。inovio pharmaceuticals inc的匯總基於最流行的技術指標 — 移動平均線、震盪指標、和樞軸點。 查看最新的 Inovio Pharmaceuticals, Inc. (INO) 股票報價、記錄、新聞及其他重要資訊，助你賣買股票及投資。